In reply: We thank Trujols and colleagues1 for sharing their insightful comments regarding the incorporation of patient‐reported outcome measures (PROMs) in clinical care. We read with interest their opinion on the involvement of patients in the development of PROMs.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Trujols J, Duran‐Sindreu S, Portella MJ. Patient‐reported outcome measures (PROMs) to guide clinical care: recommendations and challenges [letter]. Med J Aust 2022; 217: 110.
- 2. Wiering B, de Boer D, Delnoij D. Patient involvement in the development of patient‐reported outcome measures: a scoping review. Health Expect 2017; 20: 11‐23.
- 3. Agarwal A, Pain T, Levesque JF, et al. Patient‐reported outcome measures (PROMs) to guide clinical care: recommendations and challenges. Med J Aust 2022; 216: 9‐11. https://www.mja.com.au/journal/2022/216/1/patient‐reported‐outcome‐measures‐proms‐guide‐clinical‐care‐recommendations‐and
- 4. Kluzek S, Dean B, Wartolowska KA. Patient‐reported outcome measures (PROMs) as proof of treatment efficacy. BMJ Evid Based Med 2022; 27: 153‐155.
- 5. Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient‐reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016; 34: 557‐565.
- 6. Wiering B, de Boer D, Delnoij D. Patient involvement in the development of patient‐reported outcome measures: the developers’ perspective. BMC Health Serv Res 2017; 17: 635.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.